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Abstract: Introduction: Accurate diagnosis and proper treatment of oncology patients presented to emergency depart-
ment (ED) can dramatically enhance their quality of life and decrease their mortality rate. Therefore, the present
study aimed to evaluate these patients from an epidemiologic point of view as well as identifying death-related
factors. Methods: In this retrospective cross-sectional study, all the oncology patients presented to ED during
one year were evaluated using census sampling. A checklist that consisted of clinical and demographic data as
well as patients outcome was filled for each patient. Using SPSS 21, multivariate stepwise logistic regression
analysis was done to identify independent death-related factors. Results: 568 patients with the mean age of
53.64± 18.99 years were studied (56.5% male). The most common locations of tumor were brain (32.7%) and
gastrointestinal tract (27.1%). Pain (32.5%) was the most frequent chief complaint on ED arrival. The over-
all mortality rate of studied patients was 154 (27.1%), 25 (16.2%) of them in ED. Among the evaluated factors,
marital status, visiting on a weekday, arrival to ED via ambulance, type of cancer, stage of cancer, presence of
metastasis, being under treatment with chemo-radiotherapy, chief complaint on arrival, tumor location, and
admission to intensive care unit (ICU) correlated significantly with in-hospital mortality. Conclusion: The most
common type of cancer in the studied patients was solid, located in the brain or gastrointestinal tract, in stage III
and IV, metastatic, and under chemo-radiotherapy. Independent death-related factors included ICU admission,
presentation with loss of consciousness or bleeding, arrival via ambulance, cancer stage > II, neuroendocrine
and genitourinary location of cancer, and being under chemo-radiotherapy.
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1. Introduction
C
ancer is the second cause of death behind cardiovas-
cular diseases, worldwide (1). Based on the report
of international agency for research on cancer (IARC)
in GLOBOCAN 2012, the most common location and high-
est mortality rate belongs to pulmonary cancer in men and
breast cancer in women. Based on the same report, risk of
developing cancer before the age of 75 years old is 18.5%
for both sexes, while the risk of mortality due to cancer is
10.5% in the same age range. IARC reported the most com-
mon cancers in both sexes to be pulmonary, breast, colorec-
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tal, prostate, and gastric cancers, in the mentioned order (2).
Developing new treatment strategies for cancer patients has
led to an increase in their life-span and frequency of emer-
gency department (ED) visits (3). ED is one of the most im-
portant places for rapidly addressing the complaints of these
patients. Most of these patients visit ED at least once over
the course of their disease (4). Recently, many studies have
been done to evaluate the different aspects of oncology pa-
tients in ED (1, 3–11). Accurate diagnosis and proper treat-
ment of these patients in ED can dramatically enhance their
quality of life and decrease their mortality rate (8). Having
enough epidemiologic data and a proper plan for managing
these patients in ED are necessary for reaching this purpose.
Therefore, the present study was designed, aiming to evalu-
ate oncology patients presented to ED from an epidemiologic
point of view as well as identifying death-related factors.
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2. Methods
2.1. Study design and setting
In the present retrospective cross-sectional study, all the on-
cology patients presented to the ED of Shohadaye Tajrish
Hospital, Tehran, Iran, during one year from April 2014 to
March 2015, were evaluated using census sampling. No age
or sex limitations were implemented in this study. If the pa-
tient died on their way to the hospital, they were excluded.
The present study was approved by the Ethics Committee of
Shahid Beheshti University of Medical Sciences. All the re-
searchers adhered to the principles of Helsinki Declaration
during the course of the study.
2.2. Data gathering
A checklist that consisted of demographic data (age, sex,
marital status, living area, employment), type of arrival to ED,
day and time of ED visit, history of visits, patient complaints
on arrival, cancer characteristics (type, location, stage, pres-
ence and location of metastasis), special treatment charac-
teristics (chemotherapy, radiotherapy, chemo-radiotherapy),
and ED disposition and final outcome (discharge from ED,
hospitalization in oncology ward or intensive care unit (ICU),
mortality) was filled for each patient. The data were extracted
from the patients clinical profiles. By searching in the med-
ical records unit, all dead, hospitalized, and discharged on-
cology patients in ED were evaluated.
2.3. Statistical analysis
All statistical analyses were done using SPSS version 21.
Qualitative variables were reported as frequency and per-
centage, and quantitative ones as mean and standard devia-
tion. Chi square and Fisher’s tests were used to identify vari-
ables that had significant correlation with mortality. In ad-
dition, multivariate stepwise logistic regression analysis was
done on significant factors to identify independent death-
related factors. Type I error (a) was considered 0.05.
3. Results
568 patients with the mean age of 53.64 ± 18.99 years (2–
94) had visited during the study period (56.5% male). 500
(88%) patients experienced their first visit and 367 (64.7%)
were presented in the night shift. 372 (65.5%) patients ar-
rived at the ED in a private car. The most common location
of tumor were brain (32.7%) and gastrointestinal (27.1%). 247
(43.5%) of the tumors were metastatic. Tables 1 and 2 depict
the baseline characteristics of the patients based on their sur-
vival. In addition, table 3 summarizes the final outcome of
the patients. The overall mortality rate of studied patients
was 154 (27.1%), 25 (16.2%) of them in ED. Among the eval-
uated factors marital status (p = 0.009), visiting on a week-
day (p = 0.044), arrival to ED via ambulance (p < 0.001),
type of cancer (p = 0.048), stage of cancer (p < 0.001), pres-
ence of metastasis (p < 0.001), being under treatment with
chemoradiotherapy (p < 0.001), chief complaint on arrival
(p < 0.001), tumor location (p = 0.04), and hospitalization in
ICU (p < 0.001) correlated with inhospital mortality (tables 1
and 2). Table 4 shows the results of stepwise logistic regres-
sion analysis.
4. Discussion
Based on the results, the most common type of cancer in
the studied patients was solid (94.5%), located in the brain
(32.7%) or gastrointestinal tract (27.1%), in stage IV (50.4%),
metastatic (43.5%), and under treatment with chemoradio-
therapy (49.9%). Finally, 154 (27.1%) patients had died
(16.2% in ED) and more than 90% of those who had visited
ED had needed hospitalization in the oncology ward. The in-
dependent death-related factors were hospitalization in ICU,
ED presentation with loss of consciousness or bleeding, ar-
rival via ambulance, cancer stage > II, neuroendocrine and
genitourinary location of cancer, and being under chemo-
radiotherapy.
Currently, despite the advances in cancer treatment, it is still
a major health problem and cancer patients commonly face
medical emergencies and unexpected life-threatening dis-
eases (3, 12). These patients are most commonly admitted to
ED for decreasing the cancer-related symptoms, controlling
treatment side effects, oncology emergencies, simultaneous
diseases, or palliative care (7, 13, 14). Mean age of oncology
patients visiting the ED has been estimated to be between 60
to 68 years in various studies (1, 11, 15, 16). In the present
study, mean age of patients was 53.64±18.99 years (2–94) and
most were in the 50–75 age range.
Regarding sex distribution, the findings of the present study
were in line with previous studies (4, 7, 8).
Epigastric pain, nausea and vomiting, and shortness of
breath are among the frequent reported causes of ED visit in
previous studies (7, 8, 11). While, in the present study, the
most common chief complaint of the patients on ED admis-
sion was pain, which is in line with the findings of Kraft Ro-
vere et al., Mayer et al., and Barbera et al. (7, 9, 10, 15).
In the present study, most cancers were solid (73.7%), which
is similar to the Bozdemir et al. study result (88%) (11).
The most common location of tumor in our study was brain
(32.7%), followed by gastrointestinal tract (27.1%). The most
frequent reported tumor locations are lung, gastrointestinal,
and respiratory tracts in similar studies (1, 4, 7, 9–11). Out
of the 568 cancer patients presented to the ED, 90.3% were
subsequently hospitalized in the oncology department, 5.3%
were discharged, and 4.4% died. Death rate in the ED was
estimated to be 8-9% in various studies (4, 8). Lower ED mor-
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Table 1: Comparison of baseline characteristics between survived and dead patients
Variable Total Survival Death P value
Sex
Female 247 (43.5) 178 (72.1) 69 (27.9)
0.385
Male 321 (56.5) 236 (73.5) 85 (26.5)
Age (year)
1–24.9 39 (6.8) 33 (84.9) 6 (15.4)
0.003
25–49.9 173 (30.4) 136 (78.6) 37 (21.4)
50–74.9 271 (47.7) 195 (72) 76 (28)
75–99.9 85 (14.9) 50 (58.8) 35 (41.2)
Marital status
Single 63 (11.1) 54 (85.7) 9 (14.3)
0.009
Married 505 (88.9) 360 (71.3) 145 (28.7)
Employment
Employed 316 (55.6) 229 (72.5) 87 (27.5)
0.961
Unemployed 240 (42.3) 176 (73.3) 64 (26.7)
Time of arrival
Day 200 (35.2) 140 (70) 60 (30)
0.236
Night 367 (64.7) 274 (74.7) 93 (23.3)
Day of arrival
Weekend 88 (15.5) 57 (64.8) 31 (35.2)
0.044
Weekday 480 (84.5) 357 (74.4) 123 (25.6)
Living area
Urban 550 (96.8) 399 (72.5) 151 (27.5)
0.235
Rural 18 (3.2) 15 (83.3) 3 (16.7)
Transportation to ED
Ambulance 182 (32) 70 (38.5) 112 (61.5) < 0.001
Private car 372 (65.5) 334 (89.8) 38 (10.2)
Number of ED visits
1 500 (88) 360 (72) 140 (28)
0.3332 64 (11.3) 50 (78) 14 (21.9)
3 3 (5) 3 (100) 0 (0)
Type of cancer
Solid 537 (94.5) 396 (73.7) 141 (26.3)
0.048
Hematologic 31 (5.5) 18 (58.1) 13 (41.9)
Stage of cancer
I 29 (5.1) 27 (93.1) 2 (6.9)
< 0.001II 100 (17.6) 96 (96) 4 (4)
III 128 (22.5) 102 (79.7) 26 (20.3)
IV 286 (50.4) 167 (58.4) 119 (41.6)
Multiple cancers
Yes 32 (5.6) 23 (71.9) 9 (28.1)
0.517
No 536 (94.4) 391 (72.9) 145 (27.1)
Metastasis
Positive 247 (43.5) 147 (59.5) 100 (40.5) < 0.001
Negative 320 (56.3) 266 (83.1) 54 (16.9)
Treatment
Chemotherapy 140 (24.6) 95 (67.9) 45 (32.1)
< 0.001Radiotherapy 32 (5.6) 22 (68.8) 10 (31.3)
Chemo-radiotherapy 59 (57.3) 178 (72.1) 44 (42.7)
None 293 (51.6) 238 (81.2) 55 (18.8)
tality rate (4.4%) in the present study might be due to rapid
disposition of the patients to other wards and their higher
rate of hospitalization. In other words, ED mortality rate
has decreased in return to a rise in other wards mortality
rate. Based on the findings of the present study, independent
death-related factors in this study included hospitalization in
ICU, visiting due to loss of consciousness or bleeding, arrival
via ambulance, higher stage of cancer, tumor type, and being
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Table 2: Comparison of baseline characteristics between survived and dead patients (continued)
Variable Total Survival Death P value
ICU admission
Yes 20 (3.9) 6 (30) 14 (70) < 0.001
No 482 (24.1) 371 (77) 111 (23)
ED chief complaints
Fever 12 (2.1) 11 (91.7) 1 (8.3)
< 0.001
Loss of consciousness 132 (23.2) 65 (49.2) 67 (50.8)
Respiratory distress 51 (8.9) 30 (58.8) 21 (41.2)
Gastrointestinal disorder 42 (7.3) 35 (83.3) 7 (16.7)
Pain 185 (32.5) 149 (80.5) 36 (19.5)
Focal neurologic deficit 91 (16.0) 81 (89) 10 (11)
Bleeding 16 (2.8) 12 (75) 4 (25)
Ulcer 13 (2.2) 8 (61.5) 5 (38.5)
Mass 22 (3.8) 21 (95.5) 1 (4.5)
Extremity edema 4 (0.7) 2 (50) 2 (50)
Tumor location
Brain 186 (32.7) 156 (83.9) 30 (16.1)
< 0.004
Breast 56 (9.9) 40 (71.4) 16 (28.6)
Prostate 31(5.5) 18 (58.1) 13 (41.9)
Gastrointestinal 154 (27.1) 106 (68.8) 48 (31.2)
Respiratory 24 (4.2) 15 (62.5) 9 (37.5)
Genitourinary 79 (13.9) 51 (64.6) 28 (35.4)
Lymphoma 4 (0.7) 4 (100) 0 (0)
Skin 4 (0.7) 3 (75) 1 (25)
Neuroendocrine 20 (3.5) 15 (75) 5 (25)
Liposarcoma 1 (0.2) 0 (0) 1 (100)
Bone 3 (0.5) 3 (100) 0 (0)
Neck 2 (0.4) 2 (100) 0 (0)
Heart 1 (0.2) 0 (0) 1 (100)
Cholangiocarcinoma 2 (0.4) 1 (50) 1 (50)
Muscle 1 (0.2) 0 (0) 1 (100)
Location of metastasis
Brain 21 (9) 13 (61.9) 8 (38.1)
< 0.332
Bone 36 (15.5) 28 (77.8) 8 (22.2)
Lung 36 (15.5) 22 (61.1) 14 (8.1)
Multiple 57 (24.5) 24 (42.1) 33 (57.9)
Pleura 7 (3.0) 5 (71.4) 2 (28.6)
Uterus 3 (1.2) 3 (100) 0 (0)
Bladder 4 (1.7) 2 (50) 2 (50)
Liver 47 (20.2) 28 (59.6) 19 (40.4)
Pancreas 3 (1.2) 2 (66.7) 1 (33.3)
Kidney 4 (1.7) 2 (50) 2 (50)
Rectum 1 (0.4) 0 (0) 1 (100)
Peritoneum 3 (1.2) 2 (66.7) 1 (33.3)
Colon 3 (1.2) 2 (66.7) 1 (33.3)
Pelvic organs 1 (0.4) 1 (100) 0 (0)
Stomach 1 (0.4) 1 (50) 1 (50)
Abdominal 2 (0.8) 1 (50) 1 (50)
Neck 2 (0.8) 2 (100) 0 (0)
ED: emergency department; ICU: intensive care unit.
under chemo-radiotherapy. As can be seen, most of these
factors are related to severity of disease on admission. For
instance, in the studied ED, most of the patients who had ar-
rived via an ambulance were in a worse condition compared
to those who had arrived by themselves or accompanied by
relatives, and therefore died more. On the other hand, pa-
tients in a more severe condition were more commonly ad-
mitted to ICU and naturally had a higher death rate.
It seems that patients who visited the studied ED were simi-
lar to the participants of other studies from an epidemiologic
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Table 4: The results of multivariate stepwise logistic regression
analysis
Variables Odds ratio (95% CI) P value
ICU admission
Yes 4.90 (1.36- 160.61) 0.027
Chief complaint
Loss of consciousness 3.01 (1.66- 5.44) < 0.001
Bleeding 5.20 (0.98- 27.60) 0.052
Transportation to ED
Private car 0.09 (0.5- 0.17) < 0.001
Stage of cancer
II 0.17 (0.05- 0.53) 0.002
Treatment
Chemo-radiotherapy 2.16 (1.15- 4.04) 0.016
Tumor location
Neuroendocrine 4.46 (1.05- 18.94) 0.043
Genitourinary 3.85 (1.78- 8.29) 0.001
CI: confidence interval; ICU: intensive care unit.
point of view and the differences present are a result of the
natural differences in hospitals regarding patient admission
policies and available specialties. Multi-centric studies can
be helpful in this respect. We should be cautious about us-
ing the results of this study since the study design has some
limitations for this kind of conclusion.
5. Conclusion
Based on the results, the most common type of cancer in
the studied patients was solid, located in the brain or gas-
trointestinal tract, in stage III and IV, metastatic, and under
chemo-radiotherapy. The factors correlating with hospital
mortality included hospitalization in ICU, ED presentation
with loss of consciousness or bleeding, arrival via ambulance,
cancer stage> II, neuroendocrine and genitourinary location
of cancer, and being under chemo-radiotherapy.
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